Decades of overuse, misuse, and environmental antibiotic pollution has increased the global pool of resistant bacteria. With estimates of hundreds of thousands of annual human deaths and a lack of new drugs to replace old ones, antimicrobial resistance probably constitutes one of the greatest human health and sustainability challenges of the 21st century. Achieving long-term sustainable levels of antibiotic consumption while improving health and well-being is therefore a significant part of the global sustainability challenge. This session will investigate the use of resilience studies to study the antimicrobial system.
Anaïs Léger is a post-doc researcher at the Global Studies Institute at the University of Geneva. Anaïs obtained her DVM degree in 2012 at the École Nationale Vétérinaire d'Alfort (France). In 2012, she also completed a degree in Animal Health and Epidemiology in Southern Countries at the French Centre for Agricultural Research for Development (CIRAD) in Montpellier, France. From November 2015 to December 2018, Anaïs worked at SAFOSO (Bern, Switzerland) a consultancy company in veterinary public health, as a resident at the European College of Veterinary Public Health (ECVPH). She worked on several projects mainly targeting animal health and welfare, surveillance, One Health, animal health economics and antimicrobials. She completed her residency and is now a Diplomat from the ECVPH. In Mai 2018, she joined the Global Studies Institute of the University of Geneva as a post-doc researcher. She is mainly working on the AMResilience project, working on the resilience of One Health systems to antimicrobial resistance.
Didier Wernli is a Senior Researcher/Lecturer and the deputy Director for research at the Global Studies Institute of the University of Geneva. He has an appointment as a Visiting Assistant Professor at the School of Public Health of the University of Hong Kong. Didier holds a medical doctorate (MD) from the Faculty of Medicine of the University of Geneva, a master’s degree (MA) in international affairs from the Graduate Institute of International and Development studies, and an interdisciplinary doctorate (PhD) from the Global Studies Institute of the University of Geneva. Over the past ten years, Didier has developed several interdisciplinary programmes and teaching activities in global health/governance as well as collaborative research at the interface between international relations and health. Drawing on systems and complexity science, his research interests are on the global governance of infectious diseases. Didier is the co-founder and Director of the Geneva Transformative Governance Lab and a principal investigator within an international collaboration funded by JPIAMR on the resilience of One Health systems to antimicrobial resistance. Didier is also a principal investigator in the project: “Governing systemic crises in the 21st century: Learning from early Covid-19 responses in Europe”.
Chantal MorelHealth economist specializing in policies and incentives related to the prevention and treatment of infectious disease. She has spent the last 17 looking at infectious disease policy – the last 12 years of which have been focused on antimicrobial resistance (AMR) policy specifically. Much of her work has been on markets related to AMR, including for drugs, diagnostics, and a little on vaccines. But it also spans many other parts of AMR, including veterinary/farming policy, resistance surveillance, microbiology (MIC cut-offs), antibiotic and diagnostic stewardship, lego-regulatory policy/incentives.
Karl Blanchet, Professor Karl Blanchet is the Director of the Geneva Centre of Humanitarian Studies, and Professor in Humanitarian Public Health at the Faculty of Medicine, University of Geneva. Professor Blanchet has been working in health systems research at the London School of Hygiene and Tropical Medicine since 2010 and was the co-founder and co-Director of the Health in Humanitarian Crises Centre. He has a management and public health background and brings extensive experience in humanitarian contexts as a former relief worker and a researcher. Professor Blanchet’s research focuses on resilience and health systems issues in global health, specifically in post-conflict and conflict-affected countries. He has developed innovative research approaches based on complexity science and system thinking, and is currently focusing on Women, adolescent and Child Health in humanitarian settings. Karl is also developing a priority package of essential health services for countries such as Afghanistan and more generally for humanitarian crises.Professor Blanchet is also the Academic Director of InZone, an academic project working in refugee camps.Prof Blanchet is a member of the technical working group on Research on Global Health Emergencies at the Nuffield Council on Bioethics. He is also a core member of the UHC2030 Technical Working Group on support to countries with fragile or challenging operating environments, and a member of the WHO technical working group on Health Systems Assessment and the WHO technical working group on SRH in emergencies. In early 2021 Prof. Blanchet has been nominated to represent the University of Geneva in the Steering Committee of the Geneva Hub for Education in Emergencies, a new initiative of the Swiss Government. Professor Blanchet also gave an LSHTM TED Talk onhealth systems and complexity.